Schrödinger, Inc.
$12.8
▲
0.26%
2026-04-21 09:20:01
www.schrodinger.com
NMS: SDGR
Explore Schrödinger, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$944.96 M
Current Price
$12.8
52W High / Low
$27.63 / $10.95
Stock P/E
—
Book Value
$4.94
Dividend Yield
—
ROCE
-31.08%
ROE
-26.29%
Face Value
—
EPS
$-1.41
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
850
Beta
1.62
Debt / Equity
30.03
Current Ratio
2.75
Quick Ratio
2.75
Forward P/E
-8.24
Price / Sales
3.28
Enterprise Value
$553.24 M
EV / EBITDA
-3.44
EV / Revenue
2.16
Rating
Strong Buy
Target Price
$22
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Waystar Holding Corp. | $26.71 | 45.13 | $5.06 B | — | 4.48% | 3.22% | $42.55 / $20.93 | $20.25 |
| 2. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 3. | Simulations Plus, Inc. | $14.97 | — | $295 M | 0.61% | 5.18% | -41.21% | $36.45 / $11.09 | $6.31 |
| 4. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 5. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 6. | American Well Corporation | $6.61 | — | $101.3 M | — | -42.01% | -33.67% | $9.15 / $3.71 | $14.34 |
| 7. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 87.23 M | 54.32 M | 54.76 M | 59.55 M | 88.32 M | — |
| Operating Profit | -17.16 M | -45.95 M | -52.9 M | -50.89 M | -20.71 M | — |
| Net Profit | 32.51 M | -32.8 M | -43.17 M | -59.81 M | -40.22 M | — |
| EPS in Rs | 0.5 | -0.51 | -0.67 | -0.92 | -0.62 | -0.52 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 255.87 M | 207.54 M | 216.67 M | 180.96 M |
| Operating Profit | -166.9 M | -209.3 M | -177.45 M | -146.82 M |
| Net Profit | -103.27 M | -187.12 M | 40.72 M | -149.19 M |
| EPS in Rs | -1.6 | -2.89 | 0.63 | -2.31 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 726.16 M | 823.23 M | 802.96 M | 688.59 M |
| Total Liabilities | 362.11 M | 401.78 M | 254.4 M | 240.68 M |
| Equity | 364.05 M | 421.44 M | 548.56 M | 447.89 M |
| Current Assets | 519.26 M | 634.99 M | 567.8 M | 533.99 M |
| Current Liabilities | 189.14 M | 191.75 M | 133.67 M | 108.8 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 13.9 M | -157.37 M | -136.73 M | -119.68 M |
| Investing CF | 57.9 M | 148.84 M | 193.03 M | 90.02 M |
| Financing CF | 2.93 M | 10.12 M | 9.05 M | 2.11 M |
| Free CF | 12.46 M | -164.68 M | -150.14 M | -127.7 M |
| Capex | -1.44 M | -7.31 M | -13.4 M | -8.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -4.21% | 19.73% | — | — |
| Earnings Growth % | -559.54% | 127.29% | — | — |
| Profit Margin % | -90.16% | 18.79% | -82.44% | — |
| Operating Margin % | -100.85% | -81.9% | -81.13% | — |
| Gross Margin % | 63.64% | 64.93% | 55.83% | — |
| EBITDA Margin % | -97.88% | -79.34% | -78.73% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.